Address
9201 West Broadway Avenue
Minneapolis, MN 55445
United States of America (the)
Phone
763 416 2840
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
206
First IPO Date
June 30, 2021
| Name | Title | Pay | Year Born |
| Kevin Hykes | President, Chief Executive Officer & Director | 2.64M | 1966 |
| Jared Oasheim | Chief Financial Officer | 517,269 | 1983 |
| Paul Verrastro | Chief Marketing & Strategy Officer | 598,972 | 1963 |
| Robert Allen John | Chief Revenue Officer | 1.05M | 1974 |
| Philip Adamson | Chief Medical Officer | 1.1M | 1961 |
| Bonnie Handke | Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics | 0 | N/A |
| Brent Binkowski | Chief Operating Officer | 0 | 1969 |
| Gregory Morrison | Chief Human Resources Officer | 0 | 1964 |
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure. The company employs a diverse distribution strategy, leveraging its internal sales force, alongside sales agents and independent distributors, to reach markets across the United States, Germany, the wider European continent, and other global territories. Incorporated in 2000, CVRx, Inc. is headquartered in Minneapolis, Minnesota.